These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21143163)
1. Medical therapy of aortic aneurysms: a pathophysiology-based approach. Muscogiuri G; Sorice GP; Tripathy D; Chavez AO; Davalli A; Lange RA; Folli F Curr Vasc Pharmacol; 2011 Sep; 9(5):572-84. PubMed ID: 21143163 [TBL] [Abstract][Full Text] [Related]
2. A combination of PPAR-gamma agonists and HMG CoA reductase inhibitors (statins) as a new therapy for the conservative treatment of AAS (aortic aneurysm syndromes). Sorice GP; Folli F Med Hypotheses; 2009 Oct; 73(4):614-8. PubMed ID: 19577852 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of aortic aneurysm: insights from human genetics and mouse models. Wilson NK; Gould RA; Gallo MacFarlane E; Consortium ML Pharmacogenomics; 2016 Dec; 17(18):2071-2080. PubMed ID: 27922338 [TBL] [Abstract][Full Text] [Related]
4. miR-29b participates in early aneurysm development in Marfan syndrome. Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819 [TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling in aortic aneurysm: another round of controversy. Lin F; Yang X J Genet Genomics; 2010 Sep; 37(9):583-91. PubMed ID: 20933212 [TBL] [Abstract][Full Text] [Related]
9. New insights in the pathogenesis of aortic aneurysms. Loeys B; De Paepe A Verh K Acad Geneeskd Belg; 2008; 70(2):69-84. PubMed ID: 18630721 [TBL] [Abstract][Full Text] [Related]
10. Current Pharmacological Management of Aortic Aneurysm. Xiang B; Zhu S; Li J; Lai H; Wang C; Zhu K J Cardiovasc Pharmacol; 2021 Aug; 78(2):211-220. PubMed ID: 33990514 [TBL] [Abstract][Full Text] [Related]
11. Defective Connective Tissue Remodeling in Smad3 Mice Leads to Accelerated Aneurysmal Growth Through Disturbed Downstream TGF-β Signaling. van der Pluijm I; van Vliet N; von der Thusen JH; Robertus JL; Ridwan Y; van Heijningen PM; van Thiel BS; Vermeij M; Hoeks SE; Buijs-Offerman RMGB; Verhagen HJM; Kanaar R; Bertoli-Avella AM; Essers J EBioMedicine; 2016 Oct; 12():280-294. PubMed ID: 27688095 [TBL] [Abstract][Full Text] [Related]
12. Vascular fibrosis in atherosclerosis. Lan TH; Huang XQ; Tan HM Cardiovasc Pathol; 2013; 22(5):401-7. PubMed ID: 23375582 [TBL] [Abstract][Full Text] [Related]
13. Is losartan the true panacea for aneurysm disease? PRO. Collins MJ; Elefteriades JA Cardiol Clin; 2010 May; 28(2):273-7. PubMed ID: 20452541 [TBL] [Abstract][Full Text] [Related]
14. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286 [TBL] [Abstract][Full Text] [Related]
16. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice. Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794 [TBL] [Abstract][Full Text] [Related]